ArticleScientific reports2025
Exploring non-invasive biomarkers for pulmonary nodule detection based on salivary microbiomics and machine learning algorithms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microorganisms are one of the most promising biomarkers for cancer, and the relationship between microorganisms and lung cancer occurrence and development provides significant potential for pulmonary nodule (PN) diagnosis from a microbiological perspective. This study aimed to analyze the salivary microbiota features of patients with PN and assess the potential of the salivary microbiota as a non-invasive PN biomarker. We collected saliva smples from 153 patients with PN and 40 controls. Using 16 S rRNA gene sequencing, differences in α- and β-diversity and community composition between the group with PN and controls were analyzed. Subsequently, specific microbial variables were selected using six models were trained on the selected salivary microbial features. The models were evaluated using metrics, such as the area under the receiver operating characteristic curve (AUC), to identify the best-performing model. Furthermore, the Bayesian optimization algorithm was used to optimize this best-performing model. Finally, the SHapley Additive exPlanations (SHAP) interpretability framework was used to interpret the output of the optimal model and identify potential PN biomarkers. Significant differences in α- and β-diversity were observed between the group with PN and controls. Although the predominant genera were consistent between the groups, significant disparities were observed in their relative abundances. By leveraging the random forest algorithm, ten characteristic microbial variables were identified and incorporated into six models, which effectively facilitated PN diagnosis. The XGBoost model demonstrated the best performance. Further optimization of the XGBoost model resulted in a Bayesian Optimization-based XGBoost (BOXGB) model. Based on the BOXGB model, an online saliva microbiota-based PN prediction platform was developed. Lastly, SHAP analysis suggested Defluviitaleaceae_UCG-011, Aggregatibacter, Oribacterium, Bacillus, and Prevotalla are promising non-invasive PN biomarkers. This study proved salivary microbiota as a non-invasive PN biomarker, expanding the clinical diagnostic approaches for PN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.